Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-05-31 @ 9:04 AM
Study NCT ID:
NCT05007951
Status:
COMPLETED
Last Update Posted:
2024-04-08
First Post:
2021-08-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)
Sponsor:
SK Bioscience Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Covid19 | View |
Keywords: